openPR Logo
Press release

Enzyme-Linked Immunosorbent Assay Technologies Market Set To Surge Significantly During 2019

01-23-2018 08:32 AM CET | Health & Medicine

Press release from: Transparency Market Research

Enzyme-Linked Immunosorbent Assay Technologies Market Set

Enzyme-Linked Immunosorbent Assay (ELISA) is a test performed to detect the presence of antibodies in a biological liquid sample. ELISA is used as quality control check in many industry and as a diagnostic tool in plant pathology and in medicine.

Though the latest emerging technology i.e. themultiplex proteomic array platform is rapidly replacing the ELISA, its market continues to grow since it is being preferred as a secondary validation tool to confirm the results of multiplex proteomic platform. Emergence of cost effective technologies and laboratory automation are some of the major factorsthat are driving The Global ELISA Market towards growth. The existing ELISA manufacturers are currently facing price pressures due to increase in the number of market players, thereby increasing competitive rivalry. In order to survive the market competition, many market players are have begun to shift their focus on niche markets and have increased their efforts in developing innovative solutions.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1855

Geographically, the global enzyme-linked immunosorbent assay market can be categorized into North America, Europe, Asia-Pacific and rest of the world regions. North America,particularly the United States currently leads this marketand is followed by Europe due to widespread existence and early adoption of highly developed technologies and supportive economy. Asia-Pacific is a promising market for ELISA kits and is expected to undergo rapid market growth. Especially countries like China and India are promising regions, reason being rapidly growing medical tourism industry in India and China will increase the use of ELISA test as a diagnostic tool.

Some of the market players leading the enzyme-linked immunosorbent assay (ELISA) market include Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific. Inc., Life Technologies Corporation and ZEUS Scientific, Inc.

Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=1855<ype=S

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Enzyme-Linked Immunosorbent Assay Technologies Market Set To Surge Significantly During 2019 here

News-ID: 912524 • Views: 319

More Releases from Transparency Market Research

Vascular Closure Devices Market Demands, Industry Size, Supply, Sales and Manufa …
Compliance with New EU-MDR May Lead to Shortage of Medical Devices amidst COVID-19 Crisis The European Parliament recently announced the postponement of the implementation of the new Medical Device Regulation (MDR) by a year, due to the unprecedented COVID-19 (coronavirus) outbreak. This will help medtech companies in the vascular closure devices market to stabilize their operations, owing to the debilitating consequences of the pandemic. This postponement is to come in practice
Laparoscopy Devices Market Offering Trends, Share, Size, Growth Until the End of …
Risk of Aerosolization of Coronavirus May Hamper Market Growth The laparoscopy devices market is projected to experience a slowdown during the COVID-19 outbreak, as minimally invasive surgical procedures carry the risk of aerosolization of blood-borne viruses. The SAGE (Scientific Advisory Group for Emergencies) and the EAES (European Association for Endoscopic Surgeons) have recommended patients to postpone their surgeries if not urgent due to the ongoing coronavirus outbreak. SAGE and EAES have laid
Clinical Trials Market Growth Opportunities Investment Analysis Report 2020-2030
Success of Clinical Trials for COVID-19 Vaccines Boosts Market Growth The coronavirus pandemic has brought research labs and healthcare institutions under great scrutiny for accelerating the clinical trials for COVID-19 vaccines. As such, the success in these clinical trials has led to global recognition of India for supplying several lack of free doses to Brazil, Bangladesh, Algeria, and South Africa. Countries such as Sri Lanka are following suit whilst creating incremental
Prefilled Syringes Market Share And Industry Trends, Forecasts Till and Million …
Prefilled Syringes Market Outlook 2031 The global prefilled syringes market was valued at US$ 13.6 Bn in 2021 The global market is projected to advance at a CAGR of 10.1% from 2022 to 2031 The global prefilled syringes market is anticipated to reach more than US$ 35.7 Bn by the end of 2031 Report Overview: https://www.transparencymarketresearch.com/prefilled-syringes-market.html Global Prefilled Syringes Market Introduction Prefilled syringe is a disposable syringe that already contains the substance to be injected.

All 5 Releases